Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Atara Biotherapeutics (ATRA) Tax Provisions (2022 - 2025)

Historic Tax Provisions for Atara Biotherapeutics (ATRA) over the last 4 years, with Q3 2025 value amounting to $28000.0.

  • Atara Biotherapeutics' Tax Provisions rose 26470.59% to $28000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $12000.0, marking a year-over-year decrease of 3333.33%. This contributed to the annual value of -$12000.0 for FY2024, which is 18000.0% down from last year.
  • As of Q3 2025, Atara Biotherapeutics' Tax Provisions stood at $28000.0, which was up 26470.59% from $3000.0 recorded in Q2 2025.
  • Atara Biotherapeutics' 5-year Tax Provisions high stood at $28000.0 for Q3 2025, and its period low was -$19000.0 during Q3 2023.
  • Over the past 4 years, Atara Biotherapeutics' median Tax Provisions value was $3000.0 (recorded in 2025), while the average stood at $4181.8.
  • Examining YoY changes over the last 5 years, Atara Biotherapeutics' Tax Provisions showed a top increase of 45000.0% in 2023 and a maximum decrease of 29000.0% in 2023.
  • Over the past 4 years, Atara Biotherapeutics' Tax Provisions (Quarter) stood at $2000.0 in 2022, then surged by 450.0% to $11000.0 in 2023, then plummeted by 272.73% to -$19000.0 in 2024, then skyrocketed by 247.37% to $28000.0 in 2025.
  • Its Tax Provisions was $28000.0 in Q3 2025, compared to $3000.0 in Q2 2025 and -$19000.0 in Q4 2024.